GenapSys Announces $70 Million in Series D Equity Financing and Expansion of its Board of Directors prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The global market for DNA data storage should grow from $36.4 million in 2020 to $525.3 million by 2025 with a compound annual growth rate (CAGR) of 70.6% for the period of 2020-2025.
The scope of the report includes DNA data storage technologies, applications, industries, initiatives, patents and companies. The markets for DNA data storage products and services are given for the years 2019, 2020 and 2025 (forecast).
This report reviews the DNA data storage technologies, including DNA read and write technologies. It then discusses significant large-scale research initiatives that impact DNA storage, read and write applications. The main market driving forces for DNA data storage products and services are discussed.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The scope of the report includes liquid biopsy technologies, applications, industry subsegments, biomarker technologies, major funding initiatives, patents and companies. The market sizes for liquid biopsy diagnostics are given for 2019, 2020 and 2025 (forecasted).
Liquid biopsy is creating a paradigm shift in medicine, and this is opening significant market opportunities. These market segments are particularly promising for the following liquid biopsy applications: noninvasive prenatal screening for average-risk populations; cancer screening and early detection; and recurrence monitoring for cancer patients.
Biomarker types of most interest include cell-free DNA (cfDNA), circulating tumor cells (CTCs) and exosomes. Ongoing advances in sensitive molecular technologies such as next-generation DNA sequencing (NGS) and digital polymerase chain reaction (dPCR) enable the detection of biomarkers that are present
Next Generation Sequencing Market Size, Share, Trends & Forecast 2020-2025 sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.
Posted on 306
GenapSys Inc. (GenapSys), the company behind the world’s first highly accurate, affordable, and accessible gene sequencer, today announced it has named Jason Myers as its Chief Executive Officer, effective February 15, 2021. He will also join the GenapSys Board of Directors. Myers will succeed Dr. Hesaam Esfandyarpour, founder and CEO of GenapSys since 2010, who will remain as Chairman.
As a strong leader in the biotech industry with a demonstrated track record of scaling businesses and bringing innovative technologies to market, Myers will help GenapSys continue to innovate and expand the reach of its industry-leading solutions. Myers currently serves as a member of the management team and a Director at Invitae, where he leads oncology strategy development. He joined Invitae in 2020 upon the acquisition of ArcherDX, a company he founded and led as President and Chief Executive Officer.